DE MICHELE, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 6.400
EU - Europa 3.110
AS - Asia 2.181
AF - Africa 86
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 11.804
Nazione #
US - Stati Uniti d'America 6.268
SG - Singapore 1.077
IT - Italia 1.023
CN - Cina 893
NL - Olanda 430
UA - Ucraina 390
FI - Finlandia 361
DE - Germania 258
IE - Irlanda 242
SE - Svezia 139
CA - Canada 130
GB - Regno Unito 103
IN - India 88
CI - Costa d'Avorio 69
VN - Vietnam 58
FR - Francia 39
ES - Italia 32
BE - Belgio 23
IR - Iran 19
ZA - Sudafrica 16
TR - Turchia 13
BR - Brasile 11
JP - Giappone 10
GR - Grecia 9
CZ - Repubblica Ceca 8
BG - Bulgaria 7
EU - Europa 6
SI - Slovenia 6
AU - Australia 5
IL - Israele 5
KR - Corea 5
PT - Portogallo 5
RO - Romania 5
AL - Albania 4
HK - Hong Kong 4
MK - Macedonia 4
PH - Filippine 4
CH - Svizzera 3
LT - Lituania 3
AR - Argentina 2
AT - Austria 2
DK - Danimarca 2
LU - Lussemburgo 2
NO - Norvegia 2
PL - Polonia 2
RS - Serbia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CL - Cile 1
CO - Colombia 1
HU - Ungheria 1
MT - Malta 1
MX - Messico 1
MY - Malesia 1
RU - Federazione Russa 1
SD - Sudan 1
UY - Uruguay 1
Totale 11.804
Città #
Chandler 1.262
Singapore 872
Millbury 456
Jacksonville 438
Ashburn 400
Amsterdam 398
Princeton 365
Nanjing 263
Santa Clara 229
Naples 214
Beijing 165
Napoli 154
Wilmington 154
Boston 149
Ottawa 112
Des Moines 89
Nanchang 88
Woodbridge 82
Shenyang 65
Hebei 59
Dong Ket 58
Jiaxing 56
Norwalk 56
Houston 54
Seattle 50
Tianjin 33
Dallas 32
Falls Church 32
Redwood City 32
Washington 32
Boardman 30
Lawrence 30
Changsha 28
San Mateo 28
Pune 26
Augusta 25
Kunming 25
Munich 25
Rome 25
Kronberg 24
Shanghai 23
Los Angeles 19
Milan 18
Nola 18
Dublin 17
San Jose 16
Indiana 15
Helsinki 14
Ardabil 13
Dearborn 13
Telese 12
Leawood 11
Orange 11
Saint Louis 11
Toronto 11
Paris 10
Waanrode 10
Ann Arbor 9
Madrid 9
Gricignano di Aversa 8
Monmouth Junction 8
Muizenberg 8
Acerra 7
Caserta 7
Changchun 7
Guangzhou 7
Sofia 7
Torre Del Greco 7
Brno 6
Brussels 6
Fairfield 6
London 6
New York 6
Ankara 5
Atlanta 5
Bengaluru 5
Bristol 5
Florence 5
Hangzhou 5
Lanzhou 5
Monteforte Irpino 5
New Delhi 5
Pontelandolfo 5
Portici 5
Redmond 5
Salerno 5
Sassari 5
The Dalles 5
Torre Annunziata 5
Barcelona 4
Battipaglia 4
Campagna 4
Cape Town 4
Clifton 4
Hong Kong 4
Izmir 4
Koper 4
Modena 4
Mugnano di Napoli 4
Pavia 4
Totale 7.195
Nome #
Screening of ARHSP-TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion. 139
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 120
Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects. 101
Brain structural damage in Friedreich's ataxia. 91
Alteration of endosomal trafficking is associated with neurodegenerative diseases 91
DNA damage signatures in peripheral blood cells as biomarkers in prodromal huntington disease 74
Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study 73
The Italian version of the quick mild cognitive impairment (Qmci-I) screen: normative study on 307 healthy subjects 72
Ataxia with oculomotor apraxia type 1 in southern italy: late onset and variable phenotype. 66
Epoetin alfa increases frataxin production in Friedreich's ataxia without affecting hematocrit. 66
Modifications of resting state networks in spinocerebellar ataxia type 2 64
A novel mutation in SACS gene in a family from southern Italy 64
SPG5 and multiple sclerosis: clinical and genetic overlap? 63
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa. 61
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism. 61
Cognitive decline in Huntington's disease expansion gene carriers 61
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 58
Parkinsonism in adult-onset Rasmussens's encephalitis: a clinical picture presenting as corticobasal syndrome 58
Pathological laughter as onset symptom in atypical parkinsonisms 58
PERK-mediated unfolded protein response activation and oxidative stress in PARK20 fibroblasts 57
Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial 56
The Heterogeneity of Early Parkinson?s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients 56
Behavioral disorder, dementia, ataxia and rigidity in a large family with Tata box-Binding Protein mutation 55
Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosis 55
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. 55
Non-motor symptoms and cardiac innervation in SYNJ1-related parkinsonism 55
Reduced striatal [123I]FP-CIT binding in SCA2 patients without parkinsonism 54
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 54
Electrophysiologic characterization in spinocerebellar ataxia 17 53
Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17 53
Emotion Recognition and Psychological Comorbidity in Friedreich’s Ataxia 53
Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy. 53
Neurophysiological study in a Spanish family with recessive spastic ataxia of Charlevoix-Saguenay 52
Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study 52
Closing-in Phenomenon in Huntington's Disease: A Neuropsychological Marker of Frontal/Executive Dysfunction 52
A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. 51
Relative frequencies of CAG expansions in spinocerebellar ataxia and dentatorubropallidoluysian atrophy in 116 Italian families 51
The Effect of Cerebellar Degeneration on Human Sensori-motor Plasticity 51
Autosomal dominant hereditary spastic paraplegia: DHPLC-based mutation analysis of SPG4 reveals eleven novel mutations. 50
Very late onset in ataxia oculomotor apraxia type I. 50
Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy 50
Ataxia with oculomotor apraxia type 1 in Southern Italy: late onset and variable phenotype 49
Frontal defect contribution to decreasing of body mass index in Parkinson's disease patients 49
Screening for Fabry disease in a series of Parkinson’s disease patients and literature review 48
Genome-wide scan linkage analysis for Parkinson's disease: The European Genetic Study of Parkinson's disease. 48
The Sepiapterin Reductase Gene Region Reveals Association in the PARK3 locus: Analysis of Familial and Sporadic Parkinson Disease in European Populations. 48
Ambulatory monitoring of left ventricular function in patients with Parkinson's disease and postural hypotension 48
A refined physical and transcriptional map of the SPG9 locus on 10q23.3[#150]q24.2 48
Why do some Friedreich's ataxia patients retain tendon reflexes? A clinical, neurophysiological and molecular study. 48
Electrophysiological characterisation in hereditary spastic paraplegia type 5. 48
Chorea-acanthocytosis without chorea: Expanding the clinical phenotype 48
Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington's disease 48
Perseverative Behavior on Verbal Fluency Task in Patients with Huntington's Disease: a Retrospective Study on a Large Patient Sample 48
Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosum 47
Accuracy of clinical diagnostic criteria for Friedreich's ataxia. 47
Cerebellar blood flow in spinocerebellar degenerations: a single photon emission tomography study in 28 patients. 47
ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism 47
A refined physical and transcriptional map of the SPG9 locus on 10q23.3-q24.2. 46
Novel mutation of SACS gene in a Spanish family with autosomal recessive spastic ataxia 46
Complex phenotype in an Italian family with a novel mutation in SPG3A. 46
A randomized clinical trial of lithium in multiple system atrophy. 46
Long-term effect of epoetin alfa on clinical and biochemical markers in friedreich ataxia 46
Primary familial brain calcification caused by a novel homozygous MYORG mutation in a consanguineous Italian family. 46
Longitudinal study of a cohort of MSA-C patients in South Italy: survival and clinical features 46
Prevalence and features of non-motor symptoms in Wilson's disease 46
Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy. 45
Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests 45
Predictors of survival in spinocerebellar ataxia type 2 population from Southern Italy. 45
Influence of GAA expansion size and disease duration on Central Nervous System impairment in Friedreich's Ataxia. Contribution to the understanding of the pathophysiology of the disease 44
DNA damage induced by polyglutamine-expanded proteins. 44
A double-blind cross-over trial of amantadine hydrochloride in Friedreich's ataxia. 44
A case of restless leg syndrome in a family with LRRK2 gene mutation. 44
Myocardial (123)I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 44
Peripheral markers of autophagy in polyglutamine diseases 44
Adult normative values for the PATA Rate Test 44
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 44
Cutaneous sensory and autonomic denervation in Progressive Supranuclear Palsy 44
Apolipoprotein E4 is probably responsible for the chromosome 19 linkage peak for Parkinson's disease. 43
Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson's disease 43
Benign hereditary chorea: clinical and neuroimaging features in an Italian family. 43
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results. 43
Be aware of Wolfram syndrome when examining ataxic patients 43
Stability of erythropoietin repackaging in polypropylene syringes for clinical use 43
The flavor test is a sensitive tool in identifying the flavor sensorineural dysfunction in Parkinson's disease 43
PARK11 is not linked with Parkinson's disease in European families. 42
Variable phenotype in a P102L Gerstmann-Straussler-Scheinker Italian family 42
INTERGENERATIONAL INSTABILITY AND MARKED ANTICIPATION IN SCA-17. 42
Cerebral blood flow in spinocerebellar degenerations: a single photon emission tomography study in 28 patients. 42
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. 42
A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. 42
Antiphospholipid-related chorea. 42
Screening for dopa-responsive dystonia in patients with scans without evidence of dopaminergic deficiency (SWEDD). 42
Le atassie ereditarie 42
Functional MRI signal fluctuations highlight altered resting brain activity in Huntington’s disease 42
Case-control study of multiple system atrophy. 41
Autosomal dominant cerebellar ataxia type I: multimodal electrophysiological study and comparison between SCA1 and SCA2 patients 41
Chronic Pachymeningitis: a case of neurosyphilis with spastic paraparesis. 41
Autonomic nervous system abnormalities in spinocerebellar ataxia type 2: a cardiovascular neurophysiologic study. 41
Friedreich's disease. A linkage study in southern and central Italy. 41
A genetic study of Parkinson's disease. 41
Totale 5.241
Categoria #
all - tutte 59.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020578 0 0 0 0 102 24 27 16 12 108 134 155
2020/20211.218 31 81 116 98 102 161 105 51 124 33 235 81
2021/20222.069 46 19 17 31 26 66 29 88 274 188 379 906
2022/20232.941 448 254 89 258 337 310 20 218 408 427 131 41
2023/20241.796 87 252 243 143 98 160 40 282 10 28 325 128
2024/20251.492 530 555 44 91 272 0 0 0 0 0 0 0
Totale 12.400